| 臺大學術典藏 |
2020-03-06T08:25:06Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.;Chang C.-J.;Yung-Ming Jeng;Lin Y.-J.;Lin Z.-Z.;Gandhi A.K.;Liao S.-C.;Huang Z.-M.;Hsu C.;Cheng A.-L.; Ou D.-L.; Chang C.-J.; YUNG-MING JENG; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:42:25Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; Lin Z.-Z.; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2022-06-10T06:11:04Z |
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma
|
Ou D.-L.; Chang C.-J.; Jeng Y.-M.; Lin Y.-J.; ZHONG-ZHE LIN; Gandhi A.K.; Liao S.-C.; Huang Z.-M.; Hsu C.; Cheng A.-L. |
| 國立臺灣大學 |
2013 |
Potential synergistic antitumor activity between sorafenib and lenalidomide in an orthotopic murine liver cancer model.
|
Chang, Chun-Jung; Ou, Da-Liang; Lin, Yi-Jang; Cheng, Ann-Lii; Hsu, Chiun; 張純榮; 鄭安理; 許駿; 歐大諒 |
| 臺大學術典藏 |
2021-05-24T13:07:51Z |
Potential syntrophic relationship between coral-associated Prosthecochloris and its companion sulfate-reducing bacterium unveiled by genomic analysis
|
Chen, Yu Hsiang; SHAN-HUA YANG; Tandon, Kshitij; Lu, Chih Ying; Chen, Hsing Ju; Shih, Chao Jen; Tang, Sen Lin |
| 臺大學術典藏 |
2021-07-26T10:04:12Z |
Potential syntrophic relationship between coral-associated Prosthecochloris and its companion sulfate-reducing bacterium unveiled by genomic analysis
|
Chen Y.-H;Yang S.-H;Tandon K;Lu C.-Y;Chen H.-J;Shih C.-J;Tang S.-L.; Chen Y.-H; Yang S.-H; Tandon K; Lu C.-Y; Chen H.-J; Shih C.-J; Tang S.-L.; SHAN-HUA YANG |
| 國家衛生研究院 |
2018-07-30 |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, YF;Chen, L;Lin, SL;Yeh, YC;Huang, TM;Chou, YH;Chang, FC;Chen, YT;Yang, SY;Lai, TS;Wu, VC;Chu, TS;Wu, KD;(NSARF), the National Taiwan University Hospital Study Group on Acute Renal Failure;Group, Taiwan Primary Aldosteronism Investigation (TAIPAI) Study |
| 臺大學術典藏 |
2019-02-20T01:37:21Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, Yu-Feng;Chen, Likwang;Lin, Shuei-Liong;Yu-Chang Yeh;Huang, Tao-Min;Yu-Hsiang Chou;Chang, Fan-Chi;Chen, Yi-Ting;Yang, Shao-Yu;Tai-Shuan Lai;Wu, Vin-Cent;Chu, Tzong-Shinn;Wu, Kwan-Dun; Lin, Yu-Feng; Chen, Likwang; Lin, Shuei-Liong; YU-CHANG YEH; Huang, Tao-Min; YU-HSIANG CHOU; Chang, Fan-Chi; Chen, Yi-Ting; Yang, Shao-Yu; TAI-SHUAN LAI; Wu, Vin-Cent; Chu, Tzong-Shinn; Wu, Kwan-Dun |
| 臺大學術典藏 |
2019-03-07T06:42:31Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, Yu-Feng; Chen, Likwang; Lin, Shuei-Liong; YU-CHANG YEH; Huang, Tao-Min; YU-HSIANG CHOU; Chang, Fan-Chi; Chen, Yi-Ting; Yang, Shao-Yu; TAI-SHUAN LAI; Wu, Vin-Cent; Chu, Tzong-Shinn; Wu, Kwan-Dun; Lin, Yu-Feng;Chen, Likwang;Lin, Shuei-Liong;Yu-Chang Yeh;Huang, Tao-Min;Yu-Hsiang Chou;Chang, Fan-Chi;Chen, Yi-Ting;Yang, Shao-Yu;Tai-Shuan Lai;Wu, Vin-Cent;Chu, Tzong-Shinn;Wu, Kwan-Dun |
| 臺大學術典藏 |
2019-03-07T06:45:13Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin, Yu-Feng;Chen, Likwang;Lin, Shuei-Liong;Yu-Chang Yeh;Huang, Tao-Min;Yu-Hsiang Chou;Chang, Fan-Chi;Chen, Yi-Ting;Yang, Shao-Yu;Tai-Shuan Lai;Wu, Vin-Cent;Chu, Tzong-Shinn;Wu, Kwan-Dun; Lin, Yu-Feng; Chen, Likwang; Lin, Shuei-Liong; YU-CHANG YEH; Huang, Tao-Min; YU-HSIANG CHOU; Chang, Fan-Chi; Chen, Yi-Ting; Yang, Shao-Yu; TAI-SHUAN LAI; Wu, Vin-Cent; Chu, Tzong-Shinn; Wu, Kwan-Dun |
| 臺大學術典藏 |
2019-01 |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Wu, Kwan-Dun; TZONG-SHINN CHU; VIN-CENT WU; Yu-Feng Lin;Chen, Likwang;Shuei-Liong Lin;Yu-Chang Yeh;Huang, Tao-Min;Chou, Yu-Hsiang;Chang, Fan-Chi;Chen, Yi-Ting;Shao-Yu Yang;Tai-Shuan Lai;Vin-Cent Wu;Tzong-Shinn Chu;Wu, Kwan-Dun; YU-FENG LIN; Chen, Likwang; SHUEI-LIONG LIN; YU-CHANG YEH; Huang, Tao-Min; Chou, Yu-Hsiang; Chang, Fan-Chi; Chen, Yi-Ting; SHAO-YU YANG; TAI-SHUAN LAI |
| 臺大學術典藏 |
2020-05-26T03:25:54Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.;Chen L.;Lin S.-L.;Yeh Y.-C.;Huang T.-M.;Yu-Hsiang Chou;Chang F.-C.;Chen Y.-T.;Yang S.-Y.;Lai T.-S.;Wu V.-C.;Chu T.-S.;Wu K.-D.; Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; YU-HSIANG CHOU; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-09-28T07:04:26Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lai T.-S.; Chen Y.-T.; Yang S.-Y.; Chang F.-C.; Chou Y.-H.; Huang T.-M.; Yeh Y.-C.; Lin S.-L.; Chen L.; Lin Y.-F.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T05:52:20Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lai T.-S.; SHAO-YU YANG; Chen Y.-T.; Chang F.-C.; Huang T.-M.; Chou Y.-H.; Yeh Y.-C.; Lin S.-L.; Chen L.; Lin Y.-F.; Lin Y.-F.;Chen L.;Lin S.-L.;Yeh Y.-C.;Huang T.-M.;Chou Y.-H.;Chang F.-C.;Chen Y.-T.;Shao-Yu Yang;Lai T.-S.;Wu V.-C.;Chu T.-S.;Wu K.-D.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T07:20:00Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Wu K.-D.; Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; TAI-SHUAN LAI; Wu V.-C.; Chu T.-S. |
| 臺大學術典藏 |
2021-01-12T03:32:05Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
SHUEI-LIONG LIN; Chen L.; Lin Y.-F.; Lin Y.-F.;Chen L.;Shuei-Liong Lin;Yeh Y.-C.;Huang T.-M.;Chou Y.-H.;Chang F.-C.;Chen Y.-T.;Yang S.-Y.;Lai T.-S.;Wu V.-C.;Chu T.-S.;Wu K.-D.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-23T02:57:02Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Lin Y.-F.;Chen L.;Lin S.-L.;Yeh Y.-C.;Huang T.-M.;Chou Y.-H.;Chang F.-C.;Chen Y.-T.;Yang S.-Y.;Lai T.-S.;Vin-Cent Wu;Chu T.-S.;Wu K.-D.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; VIN-CENT WU; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-06-25T07:21:52Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
YU-FENG LIN; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-07-20T03:15:26Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; TZONG-SHINN CHU; Wu K.-D. |
| 臺大學術典藏 |
2021-08-23T03:43:54Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; FAN-CHI CHANG; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-08-23T23:47:20Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; YI-TING CHEN; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-11-30T04:53:36Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; Huang T.-M.; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; VIN-CENT WU; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-08-24T02:10:08Z |
Potential target-organ protection of mineralocorticoid receptor antagonist in acute kidney disease
|
Lin Y.-F.; Chen L.; Lin S.-L.; Yeh Y.-C.; TAO-MIN HUANG; Chou Y.-H.; Chang F.-C.; Chen Y.-T.; Yang S.-Y.; Lai T.-S.; Wu V.-C.; Chu T.-S.; Wu K.-D. |
| 國立臺灣大學 |
2015 |
Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
|
Liu, Chien-Ming; Chiu, Kuo-Liang; Chen, Tzu-Sheng; Chang, Shang-Miao; Yang, Shu-Yun; Chen, Li-Hsiou; Ni, Yung-Lun; Sher, Yuh-Pyng; Yu, Sung-Liang; Ma, Wen-Lung; 俞松良 |
| 國家衛生研究院 |
2019-02-15 |
Potential therapeutic effect of curcumin, a natural mTOR inhibitor, in tuberous sclerosis complex
|
Kuo, CJ;Huang, CC;Chou, SY;Lo, YC;Kao, TJ;Huang, NK;Lin, C;Lin, HC;Lin, HC;Lee, YC |
